Intramyocardial Injection of Mesenchymal Precursor Cells and Weaning From Left Ventricular Assist Device (LVAD) Support

This phase 2 clinical trial investigates whether injecting the myocardium of patients with heart failure with a high dose of mesenchymal precursor cells derived from bone marrow stem cells, compared with a sham injection, repairs myocardial damage enough to facilitate weaning from left ventricular assist devices (LVADs).
Source: JAMA - Category: General Medicine Source Type: research